Literature DB >> 30114306

Repeat Surgery in Failed Primary Vitrectomy for Macular Holes Operated With the Inverted ILM Flap Technique.

Zofia Michalewska, Jerzy Nawrocki.   

Abstract

BACKGROUND AND
OBJECTIVE: Effects of repeat surgery in failed primary full-thickness macular hole (FTMH) closure with the inverted internal limiting membrane (ILM) flap technique. PATIENTS AND METHODS: Retrospective analysis of patients operated with the inverted ILM flap technique. Optical coherence tomography was performed before initial and secondary surgeries and then at up to 12 months post-surgery.
RESULTS: During the second surgery, the inverted ILM flap created at the first attempt had returned to its original position, instead of covering the FTMH. FTMH was closed in 29 eyes after second surgery (89%) and in all eyes after third surgery. Visual acuity improved in 28 of 32 cases (87.5%). The tamponade used (either silicone oil or air) did not influence final visual results (P = .06).
CONCLUSIONS: Repeat surgery with the inverted ILM flap technique is an effective method of treatment. Silicone oil improved anatomical outcome after second surgery but did not influence visual results. [Ophthalmic Surg Lasers Imaging Retina. 2018;49:611-618.]. Copyright 2018, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30114306     DOI: 10.3928/23258160-20180803-09

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  3 in total

Review 1.  Internal limiting membrane flap technique in macular hole surgery.

Authors:  Qian Xu; Jie Luan
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

2.  Evaluation of Vision-Related Quality of Life after Autologous Internal Limiting-Membrane Transplantation for Refractory Macular Holes.

Authors:  Dongqing Yuan; Weiwei Zhang; Songtao Yuan; Ping Xie; Qinghuai Liu
Journal:  Clin Ophthalmol       Date:  2020-07-23

3.  ILM Flap Repositioning for Persistent Macular Hole.

Authors:  Gregor Kastl; Peter Heidenkummer
Journal:  Case Rep Ophthalmol       Date:  2022-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.